Journal article
5.16 A Phase 2 Randomized, Placebo-Controlled Trial of Tideglusib, an Orally Administered GSK-3 Beta Inhibitor, in the Treatment of Adolescents With ASD
Authors
Anagnostou E; Bennett TA; Thorpe K; Nicolson R
Journal
Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 57, No. 10,
Publisher
Elsevier
Publication Date
October 1, 2018
DOI
10.1016/j.jaac.2018.09.311
ISSN
0890-8567